Handelsbanken Fonder
MDGL icon

Handelsbanken Fonder’s Madrigal Pharmaceuticals MDGL Stock Holding History

Handelsbanken Fonder’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.05M Buy
5,680
+320
+6% +$164K 0.01% 658
2026
Q1 		$2.81M Buy
5,360
+280
+6% +$134K 0.01% 626
2025
Q4 		$2.96M Buy
5,080
+680
+15% +$347K 0.01% 617
2025
Q3 		$2.02M Hold
4,400
– – 0.01% 721
2025
Q2 		$1.33M Sell
4,400
-400
-8% -$119K ﹤0.01% 833
2025
Q1 		$1.59M Sell
4,800
-28,000
-85% -$9.2M 0.01% 742
2024
Q4 		$10.1M Buy
32,800
+300
+0.9% +$84.4K 0.04% 357
2024
Q3 		$6.9M Buy
32,500
+900
+3% +$230K 0.03% 396
2024
Q2 		$8.85M Buy
31,600
+9,300
+42% +$2.21M 0.04% 356
2024
Q1 		$5.96M Buy
22,300
+19,000
+576% +$4.48M 0.03% 423
2023
Q4 		$764K Buy
3,300
+500
+18% +$87.5K ﹤0.01% 927
2023
Q3 		$409K Hold
2,800
– – ﹤0.01% 1151
2023
Q2 		$647K Sell
2,800
-1,000
-26% -$271K ﹤0.01% 943
2023
Q1 		$921K Hold
3,800
– – 0.01% 726
2022
Q4 		$1.1M Hold
3,800
– – 0.01% 624
2022
Q3 		$247K Hold
3,800
– – ﹤0.01% 1351
2022
Q2 		$272K Hold
3,800
– – ﹤0.01% 1376
2022
Q1 		$373K Hold
3,800
– – ﹤0.01% 1393
2021
Q4 		$322K Buy
3,800
+1,100
+41% +$90.4K ﹤0.01% 1593
2021
Q3 		$215K Hold
2,700
– – ﹤0.01% 1646
2021
Q2 		$263K Buy
2,700
+300
+13% +$35.5K ﹤0.01% 1661
2021
Q1 		$281K Hold
2,400
– – ﹤0.01% 1465
2020
Q4 		$267K Buy
+2,400
New +$293K ﹤0.01% 1452

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Handelsbanken Fonder's MDGL Position: Q2 2026 in Review

Handelsbanken Fonder increased its Madrigal Pharmaceuticals (MDGL) stake by 6% in Q2 2026, buying an estimated $164K and bringing the position to 5,680 shares worth $3.05M. The position accounts for 0.01% of the portfolio, ranked #658.

Handelsbanken Fonder first reported a position in MDGL in Q4 2020 and has held it in 23 quarters since. The position peaked at $10.1M in Q4 2024. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Handelsbanken Fonder held 5,680 shares of Madrigal Pharmaceuticals worth $3.05M as of Q2 2026.
  • Handelsbanken Fonder bought 320 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $164K.
  • Madrigal Pharmaceuticals made up 0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #658 holding.
  • Handelsbanken Fonder first reported a position in Madrigal Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • Handelsbanken Fonder's Madrigal Pharmaceuticals position peaked at $10.1M in Q4 2024.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.